We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

46 hedge funds and large institutions have $14.7M invested in Niagen Bioscience in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $13.6M → $14.7M (+$1.14M)

0% more funds holding

Funds holding: 46 → 46 (0)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

4.95% less ownership

Funds ownership: 13.31% → 8.36% (-4.9%)

50% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 14

98% less call options, than puts

Call options by funds: $1K | Put options by funds: $47K

Holders
46
Holders Change
–
Holders Change %
0%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
7
Reduced
14
Closed
16
Calls
$1K
Puts
$47K
Net Calls
-$46K
Net Calls Change
-$46K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$646K
2
Goldman Sachs
Goldman Sachs
New York
+$519K
3
ECM
Element Capital Management
New York
+$432K
4
NSIM
North Star Investment Management
Illinois
+$371K
5
PP
Paloma Partners
Connecticut
+$337K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$3.55M
2
State Street
State Street
Massachusetts
-$891K
3
Northern Trust
Northern Trust
Illinois
-$787K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$289K
5
TCM
Tieton Capital Management
Washington
-$228K
Name Holding Trade Value Shares
Change 		Change in
Stake
PG
26
PEAK6 Group
Illinois
$53K +$43.9K +13,874 New
UBS Group
27
UBS Group
Switzerland
$51K -$19.6K -6,174 -32%
VKH
28
Virtu KCG Holdings
New York
$44K +$36.6K +11,549 New
MCM
29
MAI Capital Management
Ohio
$41K – – –
RJFSA
30
Raymond James Financial Services Advisors
Florida
$39K +$32.7K +10,334 New
AIM
31
Acrospire Investment Management
Illinois
$17K +$8.24K +2,600 +136%
OIA
32
OneDigital Investment Advisors
Kansas
$15K +$12.7K +4,000 New
PCA
33
Peddock Capital Advisors
Massachusetts
$13K +$10.7K +3,380 New
PFO
34
Pathstone Family Office
New Jersey
$11K – – –
AWM
35
Avior Wealth Management
Nebraska
$8K – – –
Morgan Stanley
36
Morgan Stanley
New York
$6K -$115K -36,186 -96%
Wells Fargo
37
Wells Fargo
California
$4K -$82.7K -26,099 -96%
HS
38
Horan Securities
United States
$4K – – –
PAM
39
Panagora Asset Management
Massachusetts
$4K +$3.59K +1,132 New
AA
40
AlphaMark Advisors
Kentucky
$3K – – –
TRCT
41
Tower Research Capital (TRC)
New York
$3K +$2.13K +672 New
Simplex Trading
42
Simplex Trading
Illinois
$3K +$2.6K +822 New
MAM
43
Meeder Asset Management
Ohio
$2K -$333 -105 -14%
BNP Paribas Financial Markets
44
BNP Paribas Financial Markets
France
$31 -$779 -246 -97%
IWM
45
IHT Wealth Management
Illinois
$21 – – –
State Street
46
State Street
Massachusetts
– -$891K -331,073 Closed
TCIM
47
TIAA CREF Investment Management
New York
– -$219K -81,255 Closed
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
– -$155K -57,620 Closed
TA
49
Teachers Advisors
New York
– -$147K -54,509 Closed
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
– -$143K -53,053 Closed
1
2
3

NAGE Hedge Fund Activity: Q2 2017 in Review

46 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q2 2017, worth a combined $14.7M — up 8.4% from $13.6M a quarter earlier.

Fund positioning in NAGE was balanced in Q2 2017: 16 funds opened new positions, 16 closed out, 7 added to existing stakes and 14 trimmed.

The largest buyer was Millennium Management, adding an estimated $646K. The largest seller was BlackRock, cutting an estimated $3.55M.

  • 46 institutional investors held Niagen Bioscience (NAGE) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $14.7M of Niagen Bioscience stock for Q2 2017, up 8.4% quarter-over-quarter.
  • 16 funds opened new Niagen Bioscience positions in Q2 2017 and 16 closed out, a net change of 0 holders.
  • The largest Niagen Bioscience buyer in Q2 2017 was Millennium Management, an estimated $646K added.
  • The largest Niagen Bioscience seller in Q2 2017 was BlackRock, an estimated $3.55M sold.

Based on aggregated 13F filings for Q2 2017.